References
- Chattopadhyay C, Kim DW, Gombos DS, et al. Uveal melanoma: from diagnosis to treatment and the science in between. Cancer 2016;122:2299–2312.
- Aronow ME, Topham AK, Singh AD. Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973-2013). Ocul Oncol Pathol 2018;4:145–151.
- Bishop KD, Olszewski AJ. Epidemiology and survival outcomes of ocular and mucosal melanomas: a population-based analysis. Int J Cancer 2014;134:2961–2971.
- Mclaughlin CC, Wu XC, Jemal A, et al. Incidence of noncutaneous melanomas in the U.S. Cancer 2005;103:1000–1007.
- Kujala E, Makitie T, Kivela T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci 2003;44:4651–4659.
- Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, et al. The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Biol 2010;11:329–341.
- Bao XL, Song H, Tang X. Clinicopathological significance of expression of IGF-1R in uveal melanoma and its association with expression of p-AKT Thr308. Zhonghua Yan Ke Za Zhi 2012;48:413–416.
- Populo H, Soares P, Rocha AS, et al. Evaluation of the mTOR pathway inocular (uvea and conjunctiva) melanoma. Melanoma Res 2010;20:107–117.
- Babchia N, Calipel A, Mouriaux F, et al. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Invest Ophthalmol Vis Sci 2010;51:421–429.
- Khalili JS, Yu X, Wang J, et al. Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner. Clin Cancer Res 2012;18:4345–4355.
- Liu ZH, Zhang SY, Yu YY, et al. (-)-4-O-(4-O-β-D-glucopyranosylcaffeoyl)quinic acid presents antitumor activity in HT-29 human colon cancer in vitro and in vivo. Mol Cell Toxicol 2015;11:457–463.
- Lin YJ, Wu YZ, Chen JP, et al. (−)-4-O-(4-O-β-D-glucopyranosylcaffeoyl) quinic acid inhibits the function of myeloid-derived suppressor cells to enhance the efficacy of anti-PD1 against colon cancer. Pharm Res 2018;35:183–191.
- Shi HB, Lan J, Yang JQ. Mechanisms of resistance to checkpoint blockade therapy. Adv Exp Med Biol 2020;1248:83–117.
- Kastelan S, Antunica AG, Oreskovic LB, et al. Immunotherapy for uveal melanoma – current knowledge and perspectives. Curr Med Chem 2020; 27:1350–1366.
- Deretic V. Autophagy in immunity and cell-autonomous defense against intracellular microbes. Immunol Rev 2011;240:92–104.
- Galluzzi L, Pedro JM, Demaria S, et al. Activating autophagy to potentiate immunogenic chemotherapy and radiation therapy. Nat Rev Clin Oncol 2017;14:247–258.
- Liu-Bryan R, Terkeltaub R. Emerging regulators of the inflammatory process in osteoarthritis. Nat Rev Rheumatol 2015;11:35–44.
- Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med 2013;368:651–662.
- Xu MY, Lee DH, Joo EJ, et al. Akebia saponin PA induces autophagic and apoptotic cell death in AGS human gastric cancer cells. Food Chem Toxicol 2013;59:703–708.
- Tang CL, Yang LQ, Jiang XL, et al. Antibiotic drug tigecycline inhibited cell proliferation and induced autophagy in gastric cancer cells. Biochem Biophys Res Commun 2014;446:105–112.
- Li YL, Luo PH, Wang JC, et al. Autophagy blockade sensitizes the anticancer activity of CA-4 via JNK-Bcl-2 pathway. Toxicol Appl Pharmacol 2014;274:319–327.
- Xu Y, Yu HM, Qin HJ, et al. Inhibition of autophagy enhances cisplatin cytotoxicity through endoplasmic reticulum stress in human cervical cancer cells. Cancer Lett 2012;314:232–243.
- Maira SM, Furet P, Stauffer F. Discovery of novel anticancer therapeutics targeting the PI3K/Akt/mTOR pathway. Future Med Chem 2009;1:137–155.
- Josephs DH, Sarker D. Pharmacodynamic biomarker development for PI3K pathway therapeutics. Transl Oncogenom 2015;7:33–49.
- Mabuchi S, Kuroda H, Takahashi R, Sasano T. The PI3K/AKT/mTOR pathway as a therapeutic target in ovarian cancer. Gynecol Oncol 2015;137:173–179.
- Liu ZB, Li XS, Simoneau AR, et al. Rhodiola rosea extracts and salidroside decrease the growth of bladder cancer cell lines via inhibition of the mTOR pathway and induction of autophagy. Mol Carcinog 2012;51:257–267.
- Fan XJ, Wang Y, Wang L, et al. Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway. Oncol Rep 2016;36:3559–3567.